NCT06500377

Brief Summary

This clinical trial compares the impact of four types of meditation practices, breathing only, focused attention only, mindfulness only, and breathing, focused attention and mindfulness combined, for relaxation in cancer survivors. Studies show that many patients with cancer experience stress and anxiety. Meditation therapy uses a variety of techniques, such as breathing, sound, or movement, that may help to decrease distress and anxiety and enhance the health and quality of life of patients with cancer. The trial is being done to find out how meditation can help cancer survivors feel relaxed and attain a peaceful state of mind.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jun 2024Jun 2026

Study Start

First participant enrolled

June 17, 2024

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2026

Last Updated

July 11, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

July 9, 2024

Last Update Submit

July 9, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Retention rate

    Feasibility will be achieved if 70% of all enrolled participants attend at least 5 full visits within 6 weeks. Descriptive statistics will be generated.

    Up to 6 weeks

  • Adherence rate

    Feasibility will be achieved if 70% of all enrolled participants complete all assessments of the program within 6 weeks. Descriptive statistics will be generated.

    Up to 6 weeks

Study Arms (4)

Arm I (breathing only meditation)

EXPERIMENTAL

Patients learn breathing only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Procedure: Biospecimen CollectionProcedure: Meditation TherapyOther: Questionnaire Administration

Arm I (focused attention only meditation)

EXPERIMENTAL

Patients learn focused attention only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Procedure: Biospecimen CollectionProcedure: Meditation TherapyOther: Questionnaire Administration

Arm III (mindfulness only meditation)

EXPERIMENTAL

Patients learn mindfulness only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Procedure: Biospecimen CollectionProcedure: Meditation TherapyOther: Questionnaire Administration

Arm IV (combined meditation)

EXPERIMENTAL

Patients learn breathing, focused attention, and mindfulness combined meditation with an instructor over 60 minutes for 3 sessions within 6 weeks. Patients also practice meditation at home and undergo saliva sample collection on study.

Procedure: Biospecimen CollectionProcedure: Meditation TherapyOther: Questionnaire Administration

Interventions

Undergo saliva sample collection

Also known as: Biological Sample Collection, Biospecimen Collected, Specimen Collection
Arm I (breathing only meditation)Arm I (focused attention only meditation)Arm III (mindfulness only meditation)Arm IV (combined meditation)

Learn breathing only meditation

Also known as: Meditation
Arm I (breathing only meditation)

Ancillary studies

Arm I (breathing only meditation)Arm I (focused attention only meditation)Arm III (mindfulness only meditation)Arm IV (combined meditation)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Documented written informed consent of the participant
  • Age: ≥ 18 years
  • Ability to understand and fluently speak English or Spanish
  • No previous training in mind-body relaxation techniques including meditation, yoga, tai chi, qigong, guided imagery, mindfulness-based stress reduction, hypnosis, or cognitive behavior therapy, that exceeds 3 hours. Additionally, no regular practice of mind-body relaxation techniques, or formal experience with mind-body relaxation techniques within the past 12 months
  • Visual Analog Scale (VAS) anxiety score of \> 3 from a range from 0 to 10. A "0" means the lowest anxiety score and a "10" means the highest anxiety score
  • Long-term cancer survivors who received surgery to treat their cancer ( \> 6 months since last treatment) with no history of chemotherapy, radiation therapy, or other systemic therapy (e.g., hormonal therapy) and/or have completely recovered from surgery OR patients identified as having pre-cancerous lesions that have been surgically treated (e.g., colon polyp that has been removed)
  • Willingness to:
  • Provide salivary alpha-amylase sample
  • Complete stress tests and study questionnaires
  • Be monitored with a Bispectral Index (BIS) device

You may not qualify if:

  • Inability to complete study required time and procedures as outlined in the study procedures section of the protocol
  • Must not have had previous serious illnesses that affect neurological functioning such as strokes, heart attacks, Parkinson disease, etc
  • Ongoing active psychiatric condition, depressive/bi-polar related disorders, anxiety, psychosis disorders, or substance use that may interfere with the study including panic disorder, major depression, schizophrenia, and bipolar disease
  • Active cancer
  • Cancer survivors who have received chemotherapy, radiation therapy, or any other systemic treatment (e.g., hormonal therapy)
  • Women who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

City of Hope Medical Center

Duarte, California, 91010, United States

RECRUITING

City of Hope at Irvine Lennar

Irvine, California, 92618, United States

RECRUITING

MeSH Terms

Interventions

Specimen HandlingMeditation

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesMind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Richard T Lee

    City of Hope Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2024

First Posted

July 15, 2024

Study Start

June 17, 2024

Primary Completion (Estimated)

June 17, 2026

Study Completion (Estimated)

June 17, 2026

Last Updated

July 11, 2025

Record last verified: 2025-07

Locations